EP1175439A4 - 49 proteines humaines secretees - Google Patents

49 proteines humaines secretees

Info

Publication number
EP1175439A4
EP1175439A4 EP00921732A EP00921732A EP1175439A4 EP 1175439 A4 EP1175439 A4 EP 1175439A4 EP 00921732 A EP00921732 A EP 00921732A EP 00921732 A EP00921732 A EP 00921732A EP 1175439 A4 EP1175439 A4 EP 1175439A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00921732A
Other languages
German (de)
English (en)
Other versions
EP1175439A1 (fr
Inventor
Steven M Ruben
George Komatsoulis
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1175439A1 publication Critical patent/EP1175439A1/fr
Publication of EP1175439A4 publication Critical patent/EP1175439A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00921732A 1999-04-09 2000-04-06 49 proteines humaines secretees Withdrawn EP1175439A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12869499P 1999-04-09 1999-04-09
US128694P 1999-04-09
US17693100P 2000-01-20 2000-01-20
US176931P 2000-01-20
PCT/US2000/009071 WO2000061629A1 (fr) 1999-04-09 2000-04-06 49 proteines humaines secretees

Publications (2)

Publication Number Publication Date
EP1175439A1 EP1175439A1 (fr) 2002-01-30
EP1175439A4 true EP1175439A4 (fr) 2002-10-09

Family

ID=26826853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00921732A Withdrawn EP1175439A4 (fr) 1999-04-09 2000-04-06 49 proteines humaines secretees

Country Status (5)

Country Link
EP (1) EP1175439A4 (fr)
JP (1) JP2003501011A (fr)
AU (1) AU4200900A (fr)
CA (1) CA2370489A1 (fr)
WO (1) WO2000061629A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001257406A1 (en) * 2000-04-26 2001-11-07 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2008289482A (ja) * 2000-11-14 2008-12-04 Corixa Corp 卵巣癌の治療および診断のための組成物および方法
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
WO2003020307A1 (fr) * 2001-08-31 2003-03-13 The General Hospital Corporation Genes induits par la proteine 2 morphogenique osseuse et polypeptides, utilisations de ceux-ci dans des techniques diagnostiques et therapeutiques
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR101254815B1 (ko) 2004-07-20 2013-09-03 제넨테크, 인크. 안지오포이에틴-유사 4 단백질의 저해제, 배합물, 그의용도
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
CN101080419B (zh) 2004-07-20 2014-07-02 健泰科生物技术公司 利用血管生成素样4蛋白的组合物和方法
AR059900A1 (es) 2006-03-17 2008-05-07 Genentech Inc Anticuerpos anti-tat226 e inmunoconjugados
JP5761915B2 (ja) * 2007-02-22 2015-08-12 ジェネンテック， インコーポレイテッド 炎症性腸疾患の検出方法
US9244071B2 (en) * 2009-01-21 2016-01-26 Massachusetts Institute Of Technology Compositions and methods for assessing cytotoxicity of single cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] "Human DNA sequence from clone RP1-68O2 on chromosome 22", XP002198453, Database accession no. Z82215 *
See also references of WO0061629A1 *

Also Published As

Publication number Publication date
AU4200900A (en) 2000-11-14
CA2370489A1 (fr) 2000-10-19
JP2003501011A (ja) 2003-01-14
WO2000061629A1 (fr) 2000-10-19
EP1175439A1 (fr) 2002-01-30

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192176A4 (fr) 49 proteines secretees humaines
EP1192278A4 (fr) 48 proteines secretees humaines
EP1175439A4 (fr) 49 proteines humaines secretees
EP1165827A4 (fr) 45 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1206573A4 (fr) 26 proteines humaines secretees
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1171460A4 (fr) 48 proteines secretees humaines
EP1165828A4 (fr) 50 proteines humaines secretees
EP1237901A4 (fr) 28 proteines secretees humaines
EP1228082A4 (fr) Proteines humaines secretees 29
EP1185285A4 (fr) 49 proteines secretees humaines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040319

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040730